M&A Deal Summary |
|
|---|---|
| Date | 2009-08-26 |
| Target | Symphony Allegro |
| Sector | Life Science |
| Buyer(s) | Alexza Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
| Employees | 28 |
| Revenue | 5M USD (2015) |
Alexza Pharmaceuticals, Inc. is a developer of drugs for acute and intermittent medical conditions. Their Staccato system aerosolizes without thermal degradation, enabling convenient delivery and rapid therapeutic onset of many small molecule drugs.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2009 M&A | 1 of 1 |